Production (Stage)
Evofem Biosciences, Inc.
EVFM
$0.0097
$0.00011.04%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 956.00K | -3.04M | -2.37M | 1.35M | -4.81M |
| Total Depreciation and Amortization | 229.00K | 323.00K | 307.00K | 7.00K | 12.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.92M | 2.78M | 968.00K | -2.50M | 2.21M |
| Change in Net Operating Assets | 5.30M | -2.47M | 631.00K | -4.00K | 2.71M |
| Cash from Operations | 560.00K | -2.41M | -459.00K | -1.14M | 123.00K |
| Capital Expenditure | -- | 0.00 | 0.00 | 0.00 | -14.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -57.00K | -46.00K | -509.00K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -57.00K | -46.00K | -509.00K | 0.00 | -14.00K |
| Total Debt Issued | -- | 0.00 | 0.00 | 397.00K | -- |
| Total Debt Repaid | -135.00K | -267.00K | -262.00K | -253.00K | -- |
| Issuance of Common Stock | -- | 5.00M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 1.26M | -- | -- |
| Repurchase of Preferred Stock | -- | -1.26M | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.00M | 0.00 | 1.00M | -- |
| Cash from Financing | -135.00K | 2.47M | 998.00K | 1.14M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 368.00K | 19.00K | 30.00K | 3.00K | 109.00K |